Working by inhibiting angiogenesis, recent studies suggest that by acting against paraprotein it is effective in the treatment of Multiple Myeloma.
Working by inhibiting angiogenesis, recent studies suggest that by acting against paraprotein it is effective in the treatment of Multiple Myeloma. Approved by the FDA in 1998 for use against leprosy, its marketer, Calgene, created the STEPS program for its safe and effective dispensation. Capable of causing phocomelia if given to persons of child bearing age, FTP, name this drug infamous for causing birth defects when given to women with morning sickness.
Working by inhibiting angiogenesis, recent studies suggest that by acting against paraprotein it is effective in the treatment of Multiple Myeloma.
Thalidomide